相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PET imaging of tau protein targets: a methodology perspective
Cristina Lois et al.
BRAIN IMAGING AND BEHAVIOR (2019)
Relationships Between Tau and Glucose Metabolism Reflect Alzheimer's Disease Pathology in Cognitively Normal Older Adults
Jenna N. Adams et al.
CEREBRAL CORTEX (2019)
Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with 18F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles
Talakad G. Lohith et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand F-18-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls
Tobey J. Betthauser et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging
Anne Maass et al.
JOURNAL OF NEUROSCIENCE (2018)
Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity
Sudeepti Southekal et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Off-Target 18F-AV-1451 Binding in the Basal Ganglia Correlates with Age-Related Iron Accumulation
Jae Yong Choi et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Preclinical Evaluation of 18F-RO6958948, 11C-RO6931643, and 11C-RO6924963 as Novel PET Radiotracers for Imaging Tau Aggregates in Alzheimer Disease
Michael Honer et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([18F]-AV-1451) Binding
Allan K. Hansen et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
The Tau Positron-Emission Tomography Tracer AV-1451 Binds With Similar Affinities to Tau Fibrils and Monoamine Oxidases
Celine Vermeiren et al.
MOVEMENT DISORDERS (2018)
Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer's Agents
Dawid Panek et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits
Ramon Velazquez et al.
AGING CELL (2018)
Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40
Harald Hampel et al.
ALZHEIMERS & DEMENTIA (2018)
[F-18]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease
Jennifer L. Whitwell et al.
ANNALS OF NEUROLOGY (2018)
Longitudinal tau PET in ageing and Alzheimer's disease
Clifford R. Jack et al.
BRAIN (2018)
Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo
Sarah L. DeVos et al.
BRAIN (2018)
Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies
Almudena Fuster-Matanzo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls
Einar M. Sigurdsson
JOURNAL OF ALZHEIMERS DISEASE (2018)
Tau Conformation as a Target for Disease-Modifying Therapy: The Role of Truncation
Petr Novak et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal
Christopher M. Lee et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo
Marc Vandermeeren et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
The sulfation code for propagation of neurodegeneration
Masahito Yamada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Subthreshold Amyloid Predicts Tau Deposition in Aging
Stephanie L. Leal et al.
JOURNAL OF NEUROSCIENCE (2018)
Characterization of 3 Novel Tau Radiopharmaceuticals, 11C-RO-963, 11C-RO-643, and 18F-RO-948, in Healthy Controls and in Alzheimer Subjects
Dean F. Wong et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy
Stuti Verma et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2018)
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study
Bruno Dubois et al.
LANCET NEUROLOGY (2018)
AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy
A. Borreca et al.
MOLECULAR NEUROBIOLOGY (2018)
Tau-targeting therapies for Alzheimer disease
Erin E. Congdon et al.
NATURE REVIEWS NEUROLOGY (2018)
Early Alzheimer-type lesions in cognitively normal subjects
Stergios Tsartsalis et al.
NEUROBIOLOGY OF AGING (2018)
Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake
Sandhitsu R. Das et al.
NEUROBIOLOGY OF AGING (2018)
Muscarinic M1 Receptor Overstimulation Disrupts Working Memory Activity for Rules in Primate Prefrontal Cortex
Susheel Vijayraghavan et al.
NEURON (2018)
Tau Kinetics in Neurons and the Human Central Nervous System (vol 97, pg 1284, 2018)
Chihiro Sato et al.
NEURON (2018)
Synaptogyrin-3 Mediates Presynaptic Dysfunction Induced by Tau
Joseph McInnes et al.
NEURON (2018)
SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease
Xiaoli Wu et al.
NEUROPHARMACOLOGY (2018)
Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy
Xiaohai Wang et al.
PLOS ONE (2018)
Dual GSK-3 beta/AChE Inhibitors as a New Strategy for Multitargeting Anti -Alzheimer's Disease Drug Discovery
Xue-Yang Jiang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau. P301S mouse model of Alzheimer's disease and frontotemporal dementia
Mei Ji et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Unconventional Secretion Mediates the Trans-cellular Spreading of Tau
Taxiarchis Katsinelos et al.
CELL REPORTS (2018)
Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct Pathways
Lewis D. Evans et al.
CELL REPORTS (2018)
Extracellular Forms of A beta and Tau from iPSC Models of Alzheimer's Disease Disrupt Synaptic Plasticity
Neng-Wei Hu et al.
CELL REPORTS (2018)
Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer's Disease
Yan Zhou et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Natural antisense transcripts in diseases: From modes of action to targeted therapies
Elzbieta Wanowska et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2018)
Inert and seed-competent tau monomers suggest structural origins of aggregation
Hilda Mirbaha et al.
ELIFE (2018)
Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease
Yakeel T. Quiroz et al.
JAMA NEUROLOGY (2018)
Associations Between Tau, beta-Amyloid, and Cognition in Parkinson Disease
Joseph R. Winer et al.
JAMA NEUROLOGY (2018)
Association of Cerebral Amyloid-beta Aggregation With Cognitive Functioning in Persons Without Dementia
Willemijn J. Jansen et al.
JAMA PSYCHIATRY (2018)
A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy
Karima Schwab et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease
Leonardo Iaccarino et al.
NEUROIMAGE-CLINICAL (2018)
Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias
Melissa C. Wren et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Sequential stages and distribution patterns of aging-related tau astrogliopathy (ARTAG) in the human brain
Gabor G. Kovacs et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau
Jean-Philippe Courade et al.
ACTA NEUROPATHOLOGICA (2018)
Biomarkers for Alzheimer's disease: current status and prospects for the future
K. Blennow et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3 beta and Tau-Aggregation Inhibitors
Annachiara Gandini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease
Andrew J. Aschenbrenner et al.
NEUROLOGY (2018)
Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease
Bahareh Eftekharzadeh et al.
NEURON (2018)
Anti-neuroinflammatory effects of SLOH in Aβ-induced BV-2 microglial cells and 3xTg-AD mice involve the inhibition of GSK-3β
Xiaoli Wu et al.
NEUROSCIENCE LETTERS (2018)
Precision Medicine through Antisense Oligonucleotide-Mediated Exon Skipping
Dunhui Li et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
In vivo quantification of neurofibrillary tangles with [18F]MK-6240
Tharick A. Pascoal et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead
Petr Novak et al.
FRONTIERS IN NEUROSCIENCE (2018)
Different tau species lead to heterogeneous tau pathology propagation and misfolding
Simon Dujardin et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Antisense oligonucleotides in neurological disorders
Claudia D. Wurster et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)
Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics
Graham McClorey et al.
BIOMEDICINES (2018)
Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia
Val J. Lowe et al.
BRAIN (2018)
Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies
Shelley L. Forrest et al.
BRAIN (2018)
17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression
K. Le Guennec et al.
MOLECULAR PSYCHIATRY (2017)
Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents
Marie Jouanne et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells
Xiaoli Wu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Design, synthesis and multitarget biological profiling of second-generation anti-Alzheimer rhein-huprine hybrids
Francisco Javier Perez-Areales et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons
Michael C. Donohue et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope
Clara Theunis et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
An emerging case for membrane pore formation as a common mechanism for the unconventional secretion of FGF2 and IL-1β
David Brough et al.
JOURNAL OF CELL SCIENCE (2017)
Tau deletion promotes brain insulin resistance
Elodie Marciniak et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Subtly Modulating Glycogen Synthase Kinase 3 β: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic Diseases
Valle Palomo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain
Sneha Narasimhan et al.
JOURNAL OF NEUROSCIENCE (2017)
Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial
Petr Novak et al.
LANCET NEUROLOGY (2017)
Tau-imaging in neurodegeneration
Gerard N. Bischof et al.
METHODS (2017)
Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency
Michael G. Agadjanyan et al.
MOLECULAR NEURODEGENERATION (2017)
The release and trans-synaptic transmission of Tau via exosomes
Yipeng Wang et al.
MOLECULAR NEURODEGENERATION (2017)
Cryo-EM structures of tau filaments from Alzheimer's disease
Anthony W. P. Fitzpatrick et al.
NATURE (2017)
A 31-residue peptide induces aggregation of tau's microtubule-binding region in cells
Jan Stoehr et al.
NATURE CHEMISTRY (2017)
Tau-based therapies in neurodegeneration: opportunities and challenges
Chuanzhou Li et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Protein O-GlcNAcylation: emerging mechanisms and functions
Xiaoyong Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
A clinicopathological approach to the diagnosis of dementia
Fanny M. Elahi et al.
NATURE REVIEWS NEUROLOGY (2017)
AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure
Shruti Mishra et al.
NEUROIMAGE (2017)
Amyloid and tau PET demonstrate region-specific associations in normal older people
Samuel N. Lockhart et al.
NEUROIMAGE (2017)
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
Anne Maass et al.
NEUROIMAGE (2017)
The association between tau PET and retrospective cortical thinning in clinically normal elderly
Molly R. LaPoint et al.
NEUROIMAGE (2017)
Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation
William A. McEwan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy
Sarah L. DeVos et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A role for Tau protein in maintaining ribosomal DNA stability and cytidine deaminase-deficient cell survival
Elias Bou Samra et al.
NATURE COMMUNICATIONS (2017)
Molecular Mechanisms of Antisense Oligonucleotides
Stanley T. Crooke
NUCLEIC ACID THERAPEUTICS (2017)
Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer's disease and other tauopathies
Fulvio Florenzano et al.
ONCOTARGET (2017)
Systemic clearance and brain distribution of carbazole-based cyanine compounds as Alzheimer's disease drug candidates
Wei Zhou et al.
SCIENTIFIC REPORTS (2017)
Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
Kok Pin Ng et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
RNA stores tau reversibly in complex coacervates
Xuemei Zhang et al.
PLOS BIOLOGY (2017)
Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex
Jorge Sepulcre et al.
JAMA NEUROLOGY (2017)
Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease
Chenjie Xia et al.
JAMA NEUROLOGY (2017)
Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden
Rachel F. Buckley et al.
JAMA NEUROLOGY (2017)
Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case
Marta Marquie et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
What is the evidence that tau pathology spreads through prion-like propagation?
Amrit Mudher et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Atypical, non-standard functions of the microtubule associated Tau protein
Ioannis Sotiropoulos et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Prophylactic Active Tau Immunization Leads to Sustained Reduction in Both Tau and Amyloid-β Pathologies in 3xTg Mice
Hameetha Rajamohamedsait et al.
SCIENTIFIC REPORTS (2017)
Motifs in the tau protein that control binding to microtubules and aggregation determine pathological effects
Aurelien Lathuiliere et al.
SCIENTIFIC REPORTS (2017)
Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data
Suzanne L. Baker et al.
DATA IN BRIEF (2017)
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease
Alexandre Bejanin et al.
BRAIN (2017)
[F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging
Marta Marquie et al.
ACTA NEUROPATHOLOGICA (2017)
Distinct 18F-AV-1451 tau PET retention patterns in early-and late-onset Alzheimer's disease
Michael Scholl et al.
BRAIN (2017)
Protein astrogliopathies in human neurodegenerative diseases and aging
Gabor G. Kovacs et al.
BRAIN PATHOLOGY (2017)
Exposure of the Amino Terminus of Tau Is a Pathological Event in Multiple Tauopathies
Benjamin Combs et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro
Chloe K. Nobuhara et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Fluorodeoxyglucose Metabolism Associated With Tau-Amyloid Interaction Predicts Memory Decline
Bernard J. Hanseeuw et al.
ANNALS OF NEUROLOGY (2017)
Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals
Duygu Tosun et al.
BRAIN (2017)
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition
Michael J. Pontecorvo et al.
BRAIN (2017)
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2017)
Tau Positron Emission Tomographic Imaging in Aging and Early Alzheimer Disease
Keith A. Johnson et al.
ANNALS OF NEUROLOGY (2016)
EVALUATION OF TAU BURDEN IN A CROSS-SECTIONAL COHORT OF ALZHEIMER’S DISEASE SUBJECTS USING [18F]GTP1 (GENENTECH TAU PROBE 1)
Sandra Sanabria Bohorquez et al.
Alzheimers & Dementia (2016)
In Vivo Cortical Spreading Pattern of Tau and Amyloid in the Alzheimer Disease Spectrum
Hanna Cho et al.
ANNALS OF NEUROLOGY (2016)
Design and synthesis of curcumin derivatives as tau and amyloid β dual aggregation inhibitors
Michiaki Okuda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology
Helen Ling et al.
BRAIN (2016)
18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
Ruben Smith et al.
BRAIN (2016)
Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages
Adam J. Schwarz et al.
BRAIN (2016)
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease
Rik Ossenkoppele et al.
BRAIN (2016)
The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging
Brian A. Gordon et al.
BRAIN (2016)
Lamin Dysfunction Mediates Neurodegeneration in Tauopathies
Bess Frost et al.
CURRENT BIOLOGY (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease
Mudasir Maqbool et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Adeno-Associated Virus-Based Gene Therapy for CNS Diseases
Michael Hocquemiller et al.
HUMAN GENE THERAPY (2016)
Human Truncated Tau Induces Mature Neurofibrillary Pathology in a Mouse Model of Human Tauopathy
Ivana Zimova et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Co-immunoprecipitation with Tau Isoform-specific Antibodies Reveals Distinct Protein Interactions and Highlights a Putative Role for 2N Tau in Disease
Chang Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Pathological Tau Promotes Neuronal Damage by Impairing Ribosomal Function and Decreasing Protein Synthesis
Shelby Meier et al.
JOURNAL OF NEUROSCIENCE (2016)
In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain
Jorge Sepulcre et al.
JOURNAL OF NEUROSCIENCE (2016)
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
Serge Gauthier et al.
LANCET (2016)
Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy
Erin E. Congdon et al.
MOLECULAR NEURODEGENERATION (2016)
Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer's Disease
Federica Prati et al.
MOLECULES (2016)
Neuronal activity enhances tau propagation and tau pathology in vivo
Jessica W. Wu et al.
NATURE NEUROSCIENCE (2016)
Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies
Benjamin Combs et al.
NEUROBIOLOGY OF DISEASE (2016)
Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model
Kathleen M. Schoch et al.
NEURON (2016)
PET Imaging of Tau Deposition in the Aging Human Brain
Michael Schoell et al.
NEURON (2016)
No Overt Deficits in Aged Tau-Deficient C57Bl/6.Mapttm1(EGFP)Kit GFP Knockin Mice
Annika van Hummel et al.
PLOS ONE (2016)
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease
Matthew R. Brier et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement
Seung-Hye Lee et al.
CELL REPORTS (2016)
Loss of Bin1 Promotes the Propagation of Tau Pathology
Sara Calafate et al.
CELL REPORTS (2016)
Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy
Liang Wang et al.
JAMA NEUROLOGY (2016)
Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease
Gerard N. Bischof et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
An autoradiographic evaluation of AV-1451 Tau PET in dementia
Val J. Lowe et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
3D Visualization of the Temporal and Spatial Spread of Tau Pathology Reveals Extensive Sites of Tau Accumulation Associated with Neuronal Loss and Recognition Memory Deficit in Aged Tau Transgenic Mice
Hongjun Fu et al.
PLOS ONE (2016)
Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda
Masanori Yagi et al.
SCIENTIFIC REPORTS (2016)
Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine
Gabor G. Kovacs
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies
Goran Simic et al.
BIOMOLECULES (2016)
Chloroquine and Chloroquinoline Derivatives as Models for the Design of Modulators of Amyloid Peptide Precursor Metabolism
Patricia Melnyk et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Antisense oligonucleotides in therapy for neurodegenerative disorders
Melvin M. Evers et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
A fresh perspective from immunologists and vaccine researchers: Active vaccination strategies to prevent and reverse Alzheimer's disease
Michael G. Agadjanyan et al.
ALZHEIMERS & DEMENTIA (2015)
Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
Marta Marquie et al.
ANNALS OF NEUROLOGY (2015)
Nuclear Magnetic Resonance Spectroscopy Characterization of Interaction of Tau with DNA and Its Regulation by Phosphorylation
Haoling Qi et al.
BIOCHEMISTRY (2015)
Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain
Nicole Maphis et al.
BRAIN (2015)
Distinct Therapeutic Mechanisms of Tau Antibodies PROMOTING MICROGLIAL CLEARANCE VERSUS BLOCKING NEURONAL UPTAKE
Kristen E. Funk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β
Keith A. Vossel et al.
JOURNAL OF CELL BIOLOGY (2015)
C-Terminally Truncated Forms of Tau, But Not Full-Length Tau or Its C-Terminal Fragments, Are Released from Neurons Independently of Cell Death
Daniel Kanmert et al.
JOURNAL OF NEUROSCIENCE (2015)
Rescue of impaired late-phase long-term depression in a tau transgenic mouse model
Tariq Ahmed et al.
NEUROBIOLOGY OF AGING (2015)
Human secreted tau increases amyloid-beta production
Jessica Bright et al.
NEUROBIOLOGY OF AGING (2015)
Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging
B. Ghetti et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)
Neuropathology of tauopathies: principles and practice
G. G. Kovacs
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)
Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy
Naomi Kouri et al.
NATURE COMMUNICATIONS (2015)
A mechanistic model of tau amyloid aggregation based on direct observation of oligomers
Sarah L. Shammas et al.
NATURE COMMUNICATIONS (2015)
Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody
Wenjie Luo et al.
SCIENTIFIC REPORTS (2015)
Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms
Maxime Derisbourg et al.
SCIENTIFIC REPORTS (2015)
Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains
Susana Boluda et al.
ACTA NEUROPATHOLOGICA (2015)
Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE-1 and GSK-3β Inhibitors
Federica Prati et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies
Chun-ling Dai et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice
Arne Ittner et al.
JOURNAL OF NEUROCHEMISTRY (2015)
PE859, a Novel Tau Aggregation Inhibitor, Reduces Aggregated Tau and Prevents Onset and Progression of Neural Dysfunction In Vivo
Michiaki Okuda et al.
PLOS ONE (2015)
Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models
Sethu Sankaranarayanan et al.
PLOS ONE (2015)
Passive immunotherapy of tauopathy targeting pSer413-tau: a pilot study in mice
Tomohiro Umeda et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Anti-tau antibody reduces insoluble tau and decreases brain atrophy
Kiran Yanamandra et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Complex Disposition of Methylthioninium Redox Forms Determines Efficacy in Tau Aggregation Inhibitor Therapy for Alzheimer's Disease
Thomas C. Baddeley et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Primary age-related tauopathy (PART): a common pathology associated with human aging
John F. Crary et al.
ACTA NEUROPATHOLOGICA (2014)
Genetic Ablation of Tau Mitigates Cognitive Impairment Induced by Type 1 Diabetes
Serena Abbondante et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Tau Reduction Prevents Disease in a Mouse Model of Dravet Syndrome
Ania L. Gheyara et al.
ANNALS OF NEUROLOGY (2014)
Tau-aggregation inhibitor therapy for Alzheimer's disease
Claude M. Wischik et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease
Ludovic Collin et al.
BRAIN (2014)
Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer’s Disease
Kris Simone Tranches Dias et al.
Current Neuropharmacology (2014)
Tau Protein Provides DNA with Thermodynamic and Structural Features which are Similar to those Found in Histone-DNA Complex
Sergio Camero et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Vaccination with Sarkosyl Insoluble PHF-Tau Decrease Neurofibrillary Tangles Formation in Aged Tau Transgenic Mouse Model: A Pilot Study
Kunie Ando et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Neuronal activity regulates extracellular tau in vivo
Kaoru Yamada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Glial and Neuronal Tau Pathology in Tauopathies: Characterization of Disease-Specific Phenotypes and Tau Pathology Progression
Isidre Ferrer et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)
Activity-Dependent Tau Protein Translocation to Excitatory Synapse Is Disrupted by Exposure to Amyloid-Beta Oligomers
Marie Lise Frandemiche et al.
JOURNAL OF NEUROSCIENCE (2014)
Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles
Diana L. Castillo-Carranza et al.
JOURNAL OF NEUROSCIENCE (2014)
Motor and cognitive deficits in aged tau knockout mice in two background strains
Peng Lei et al.
MOLECULAR NEURODEGENERATION (2014)
Tau promotes neurodegeneration through global chromatin relaxation
Bess Frost et al.
NATURE NEUROSCIENCE (2014)
Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion
Tariq Ahmed et al.
NEUROBIOLOGY OF AGING (2014)
Seizure resistance without parkinsonism in aged mice after tau reduction
Zhiyong Li et al.
NEUROBIOLOGY OF AGING (2014)
AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons
G. Amadoro et al.
NEUROBIOLOGY OF DISEASE (2014)
Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies
David W. Sanders et al.
NEURON (2014)
p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice
Ken C. Walls et al.
NEUROSCIENCE LETTERS (2014)
Ectosomes: A New Mechanism for Non-Exosomal Secretion of Tau Protein
Simon Dujardin et al.
PLOS ONE (2014)
Tau Reduction Diminishes Spatial Learning and Memory Deficits after Mild Repetitive Traumatic Brain Injury in Mice
Jason S. Cheng et al.
PLOS ONE (2014)
SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination
Hong-Bin Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions
Marie Violet et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer's disease
Eva Kontsekova et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model
Eva Kontsekova et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Active immunotherapy options for Alzheimer's disease
Bengt Winblad et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Doubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer's Disease Like Tau Aggregation
Monique Richter et al.
VACCINES (2014)
Globular glial tauopathies (GGT): consensus recommendations
Zeshan Ahmed et al.
ACTA NEUROPATHOLOGICA (2013)
NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model
Sylvie Burnouf et al.
AGING CELL (2013)
Physiological release of endogenous tau is stimulated by neuronal activity
Amy M. Pooler et al.
EMBO REPORTS (2013)
Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study
Teodoro del Ser et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Small Misfolded Tau Species Are Internalized via Bulk Endocytosis and Anterogradely and Retrogradely Transported in Neurons
Jessica W. Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Two Novel Tau Antibodies Targeting the 396/404 Region Are Primarily Taken Up by Neurons and Reduce Tau Protein Pathology
Jiaping Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer's-Like Tauopathy
Michiyo Iba et al.
JOURNAL OF NEUROSCIENCE (2013)
Tau Loss Attenuates Neuronal Network Hyperexcitability in Mouse and Drosophila Genetic Models of Epilepsy
Jerrah K. Holth et al.
JOURNAL OF NEUROSCIENCE (2013)
Antisense Reduction of Tau in Adult Mice Protects against Seizures
Sarah L. DeVos et al.
JOURNAL OF NEUROSCIENCE (2013)
T-cell epitope-dependent immune response in inbred (C57BL/6J, SJL/J, and C3H/HeN) and transgenic P301S and Tg2576 mice
Monique Richter et al.
JOURNAL OF PEPTIDE SCIENCE (2013)
Tau pathology and neurodegeneration
Maria Grazia Spillantini et al.
LANCET NEUROLOGY (2013)
Age-appropriate cognition and subtle dopamine-independent motor deficits in aged Tau knockout mice
Meaghan Morris et al.
NEUROBIOLOGY OF AGING (2013)
Meta-analysis of amyloid-cognition relations in cognitively normal older adults
Trey Hedden et al.
NEUROLOGY (2013)
Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
Kiran Yanamandra et al.
NEURON (2013)
Tau Passive Immunotherapy in Mutant P301L Mice: Antibody Affinity versus Specificity
Cristina d'Abramo et al.
PLOS ONE (2013)
Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
Clara Theunis et al.
PLOS ONE (2013)
Increasing Brain Protein O-GlcNAc-ylation Mitigates Breathing Defects and Mortality of Tau.P301L Mice
Peter Borghgraef et al.
PLOS ONE (2013)
Brain homogenates from human tauopathies induce tau inclusions in mouse brain
Florence Clavaguera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
Brandon B. Holmes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Tau degradation: The ubiquitin-proteasome system versus the autophagy-lysosome system
Min Jae Lee et al.
PROGRESS IN NEUROBIOLOGY (2013)
The self-perpetuating tau truncation circle
Norbert Zilka et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Roles of Glycogen Synthase Kinase 3 in Alzheimer's Disease
Zhiyou Cai et al.
CURRENT ALZHEIMER RESEARCH (2012)
Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THY-Tau22 Mouse Model: A Suitable Therapeutic Approach
Laetitia Troquier et al.
CURRENT ALZHEIMER RESEARCH (2012)
Trans-cellular Propagation of Tau Aggregation by Fibrillar Species
Najla Kfoury et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways
Norbert Zilka et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
Peng Lei et al.
NATURE MEDICINE (2012)
First transgenic rat model developing progressive cortical neurofibrillary tangles
Peter Filipcik et al.
NEUROBIOLOGY OF AGING (2012)
Constitutive secretion of tau protein by an unconventional mechanism
Xiyun Chai et al.
NEUROBIOLOGY OF DISEASE (2012)
Tau Overexpression Results in Its Secretion via Membrane Vesicles
Diana Simon et al.
NEURODEGENERATIVE DISEASES (2012)
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
Alix de Calignon et al.
NEURON (2012)
Trans-Synaptic Spread of Tau Pathology In Vivo
Li Liu et al.
PLOS ONE (2012)
Hyperphosphorylation and Cleavage at D421 Enhance Tau Secretion
Vanessa Plouffe et al.
PLOS ONE (2012)
Differential Effects of an O-GlcNAcase Inhibitor on Tau Phosphorylation
Yang Yu et al.
PLOS ONE (2012)
Long-Term Follow-Up After Gene Therapy for Canavan Disease
Paola Leone et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Tyrosine Nitration within the Pro line-Rich Region of Tau in Alzheimer's Disease
Juan F. Reyes et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Multi-Target-Directed Ligands in Alzheimer's Disease Treatment
M. Bajda et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Nuclear Tau, a Key Player in Neuronal DNA Protection
Audrey Sultan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models REDUCTION OF TAU PATHOLOGY AND DELAY OF DISEASE PROGRESSION
Xiyun Chai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Characterization of Prefibrillar Tau Oligomers in Vitro and in Alzheimer Disease
Kristina R. Patterson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
Allal Boutajangout et al.
JOURNAL OF NEUROCHEMISTRY (2011)
In Vivo Microdialysis Reveals Age-Dependent Decrease of Brain Interstitial Fluid Tau Levels in P301S Human Tau Transgenic Mice
Kaoru Yamada et al.
JOURNAL OF NEUROSCIENCE (2011)
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
Guenter U. Hoeglinger et al.
NATURE GENETICS (2011)
Selective Neuronal Vulnerability in Neurodegenerative Diseases: from Stressor Thresholds to Degeneration
Smita Saxena et al.
NEURON (2011)
Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
Mian Bi et al.
PLOS ONE (2011)
Prevalence of dementia disorders in the oldest-old: an autopsy study
Kurt A. Jellinger et al.
ACTA NEUROPATHOLOGICA (2010)
Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden
Gil D. Rabinovici et al.
BRAIN (2010)
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Lars M. Ittner et al.
CELL (2010)
Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice
Moran Boimel et al.
EXPERIMENTAL NEUROLOGY (2010)
Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors
Jesus Avila et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Spinal muscular atrophy: mechanisms and therapeutic strategies
Christian L. Lorson et al.
HUMAN MOLECULAR GENETICS (2010)
A NH2 Tau Fragment Targets Neuronal Mitochondria at AD Synapses: Possible Implications for Neurodegeneration
Giuseppina Amadoro et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Tissue-nonspecific Alkaline Phosphatase Promotes the Neurotoxicity Effect of Extracellular Tau
Miguel Diaz-Hernandez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
Allal Boutajangout et al.
JOURNAL OF NEUROSCIENCE (2010)
New evidences on Tau-DNA interactions and relevance to neurodegeneration
Vasudevaraju Padmaraju et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration
Brian R. Hoover et al.
NEURON (2010)
Tau protein and tau aggregation inhibitors
Bruno Bulic et al.
NEUROPHARMACOLOGY (2010)
Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)
Donna L. Mallery et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies
Norbert Zilka et al.
ACTA NEUROPATHOLOGICA (2009)
Development of Tau Aggregation Inhibitors for Alzheimer's Disease
Bruno Bulic et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Methylene blue and Alzheimer's disease
Murat Oz et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Identification of Aminothienopyridazine Inhibitors of Tau Assembly by Quantitative High-Throughput Screening
Alex Crowe et al.
BIOCHEMISTRY (2009)
Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing
Teresa Rodriguez-Martin et al.
HUMAN MOLECULAR GENETICS (2009)
Propagation of Tau Misfolding from the Outside to the Inside of a Cell
Bess Frost et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells
A. Gomez-Ramos et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
Tau exon 10 alternative splicing and tauopathies
Fei Liu et al.
MOLECULAR NEURODEGENERATION (2008)
Haplotype-specific expression of the N-terminal exons 2 and 3 at the human MAPT locus
Tara M. Caffrey et al.
NEUROBIOLOGY OF AGING (2008)
Binding to the Minor Groove of the Double-Strand, Tau Protein Prevents DNA from Damage by Peroxidation
Yan Wei et al.
PLOS ONE (2008)
Interaction of tau protein with the dynactin complex
Enrico Magnani et al.
EMBO JOURNAL (2007)
Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements
Ayodeji A. Asuni et al.
JOURNAL OF NEUROSCIENCE (2007)
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
Erik D. Roberson et al.
SCIENCE (2007)
The jaws of the Tau-microtubule interaction
Marco D. Mukrasch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1
Edda Thies et al.
JOURNAL OF NEUROSCIENCE (2007)
The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts
Amanda J. Myers et al.
NEUROBIOLOGY OF DISEASE (2007)
Intrinsically disordered proteins in the neurodegenerative processes: Formation of tau protein paired helical filaments and their analysis
Rostislav Skrabana et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2006)
Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies
Matthew R. Reynolds et al.
JOURNAL OF NEUROSCIENCE (2006)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
Extracellular tau is toxic to neuronal cells
Alberto Gomez-Ramos et al.
FEBS LETTERS (2006)
Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo
Norbert Zilka et al.
FEBS LETTERS (2006)
Incidence and predictors of seizures in patients with Alzheimer's disease
JC Amatniek et al.
EPILEPSIA (2006)
Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and α-synuclein
V Dorval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron
NK Singh et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration
AM Pittman et al.
JOURNAL OF MEDICAL GENETICS (2005)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase
P Derkinderen et al.
JOURNAL OF NEUROSCIENCE (2005)
Environmental reduplicative paramnesia in a case of atypical Alzheimer's disease
A Von Gunten et al.
NEUROCASE (2005)
p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death
M Hamdane et al.
JOURNAL OF CELL SCIENCE (2005)
Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins
S Taniguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Simultaneous measurement of β-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology
A Olsson et al.
CLINICAL CHEMISTRY (2005)
Tau aggregation is driven by a transition from random coil to beta sheet structure
M von Bergen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Tau protein as a differential biomarker of tauopathies
N Sergeant et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Staging of argyrophilic grains: An age-associated tauopathy
Y Saito et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury
MD Ikonomovic et al.
EXPERIMENTAL NEUROLOGY (2004)
Nitration of tau protein is linked to neurodegeneration in tauopathies
T Horiguchi et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease
P Giannakopoulos et al.
NEUROLOGY (2003)
Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease
K Kobayashi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Tau could protect DNA double helix structure
Q Hua et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2003)
Office of rare diseases neuropathologic criteria for corticobasal degeneration
DW Dickson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
Natively unfolded proteins: A point where biology waits for physics
VN Uversky
PROTEIN SCIENCE (2002)
Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease
F Liu et al.
FEBS LETTERS (2002)
Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease
JC Augustinack et al.
ACTA NEUROPATHOLOGICA (2002)
In vitro assembly of tau protein:: Mapping the regions involved in filament formation
M Pérez et al.
BIOCHEMISTRY (2001)
Neurodegenerative tauopathies
VMY Lee et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes
Y Takei et al.
JOURNAL OF CELL BIOLOGY (2000)
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
L Buée et al.
BRAIN RESEARCH REVIEWS (2000)
Neural substrates of spatial and temporal disorientation in Alzheimer's disease
P Giannakopoulos et al.
ACTA NEUROPATHOLOGICA (2000)
Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming β structure
M von Bergen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Clinical validity of Braak neuropathological staging in the oldest-old
G Gold et al.
ACTA NEUROPATHOLOGICA (2000)
Conformational change as one of the earliest alterations of tan in Alzheimer's disease
CL Weaver et al.
NEUROBIOLOGY OF AGING (2000)
分享论文
